2020 Q2 Form 10-Q Financial Statement

#000143774920017101 Filed on August 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q1
Revenue $26.37M $36.03M
YoY Change -44.8% 5.57%
Cost Of Revenue $14.75M $18.72M
YoY Change -32.8% 11.47%
Gross Profit $11.62M $17.31M
YoY Change -55.0% -0.14%
Gross Profit Margin 44.08% 48.05%
Selling, General & Admin $19.56M $21.63M
YoY Change -12.11% 16.74%
% of Gross Profit 168.31% 124.96%
Research & Development $2.991M $3.706M
YoY Change -8.62% 4.22%
% of Gross Profit 25.73% 21.41%
Depreciation & Amortization $360.0K $411.0K
YoY Change -12.2% 61.81%
% of Gross Profit 3.1% 2.37%
Operating Expenses $22.56M $25.34M
YoY Change -11.66% 14.73%
Operating Profit -$10.93M -$8.026M
YoY Change -3755.85% 69.0%
Interest Expense $0.00 -$80.00K
YoY Change -100.0% -180.0%
% of Operating Profit
Other Income/Expense, Net $3.000K -$79.00K
YoY Change -93.48% -180.61%
Pretax Income -$10.93M -$8.105M
YoY Change -3267.54% 74.26%
Income Tax $500.0K $115.0K
% Of Pretax Income
Net Earnings -$11.39M -$8.220M
YoY Change -2037.76% 304.53%
Net Earnings / Revenue -43.21% -22.82%
Basic Earnings Per Share -$0.67 -$0.59
Diluted Earnings Per Share -$0.67 -$0.59
COMMON SHARES
Basic Shares Outstanding 17.06M shares 14.02M
Diluted Shares Outstanding 17.06M shares 14.02M

Balance Sheet

Concept 2020 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.60M $27.10M
YoY Change 47.0% 12.92%
Cash & Equivalents $33.66M $19.16M
Short-Term Investments $12.90M $7.900M
Other Short-Term Assets $5.300M $4.900M
YoY Change 17.78% 88.46%
Inventory $31.24M $26.66M
Prepaid Expenses
Receivables $13.83M $19.14M
Other Receivables $0.00 $0.00
Total Short-Term Assets $96.93M $77.76M
YoY Change 10.13% 0.44%
LONG-TERM ASSETS
Property, Plant & Equipment $2.417M $2.407M
YoY Change -14.71% 8.72%
Goodwill $1.339M $1.339M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.733M $5.960M
YoY Change -25.0% 11.05%
Total Long-Term Assets $16.49M $19.60M
YoY Change -17.29% -36.18%
TOTAL ASSETS
Total Short-Term Assets $96.93M $77.76M
Total Long-Term Assets $16.49M $19.60M
Total Assets $113.4M $97.36M
YoY Change 5.07% -9.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.68M $10.34M
YoY Change 2.1% 25.97%
Accrued Expenses $20.42M $21.79M
YoY Change -24.43% 8.49%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $500.0K $600.0K
YoY Change -16.67%
Total Short-Term Liabilities $44.64M $46.90M
YoY Change -15.56% 26.28%
LONG-TERM LIABILITIES
Long-Term Debt $7.500M $400.0K
YoY Change 837.5%
Other Long-Term Liabilities $345.0K $0.00
YoY Change -55.88% -100.0%
Total Long-Term Liabilities $345.0K $0.00
YoY Change -55.88% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $44.64M $46.90M
Total Long-Term Liabilities $345.0K $0.00
Total Liabilities $60.92M $58.24M
YoY Change -5.94% 44.61%
SHAREHOLDERS EQUITY
Retained Earnings -$60.17M -$32.23M
YoY Change 90.15% -647.38%
Common Stock $112.7M $71.41M
YoY Change 50.45% 15.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $52.50M $39.12M
YoY Change
Total Liabilities & Shareholders Equity $113.4M $97.36M
YoY Change 5.07% -9.96%

Cashflow Statement

Concept 2020 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$11.39M -$8.220M
YoY Change -2037.76% 304.53%
Depreciation, Depletion And Amortization $360.0K $411.0K
YoY Change -12.2% 61.81%
Cash From Operating Activities -$5.980M -$7.953M
YoY Change -248.39% -20.84%
INVESTING ACTIVITIES
Capital Expenditures -$210.0K $65.00K
YoY Change -16.0% -37.5%
Acquisitions
YoY Change
Other Investing Activities -$8.140M $1.610M
YoY Change -304.01% -81.39%
Cash From Investing Activities -$8.340M $1.549M
YoY Change -323.59% -81.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 33.22M -490.0K
YoY Change 4389.19% -72.43%
NET CHANGE
Cash From Operating Activities -5.980M -7.953M
Cash From Investing Activities -8.340M 1.549M
Cash From Financing Activities 33.22M -490.0K
Net Change In Cash 18.90M -6.894M
YoY Change 122.35% 110.57%
FREE CASH FLOW
Cash From Operating Activities -$5.980M -$7.953M
Capital Expenditures -$210.0K $65.00K
Free Cash Flow -$5.770M -$8.018M
YoY Change -234.81% -21.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4832000 USD
CY2020Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3155000 USD
CY2019Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4832000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.80 pure
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
11800000 USD
CY2020Q1 us-gaap Deferred Revenue
DeferredRevenue
12969000 USD
CY2019Q1 us-gaap Deferred Revenue
DeferredRevenue
12475000 USD
CY2019Q4 us-gaap Deferred Revenue
DeferredRevenue
14222000 USD
CY2018Q4 us-gaap Deferred Revenue
DeferredRevenue
11855000 USD
CY2020Q2 cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
2356000 USD
CY2019Q2 cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
5309000 USD
cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
5582000 USD
cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
9451000 USD
CY2020Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
3546000 USD
CY2019Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
3925000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
8025000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
7447000 USD
CY2020Q2 us-gaap Deferred Revenue
DeferredRevenue
11779000 USD
CY2019Q2 us-gaap Deferred Revenue
DeferredRevenue
13859000 USD
CY2020Q2 us-gaap Deferred Revenue
DeferredRevenue
11779000 USD
CY2019Q2 us-gaap Deferred Revenue
DeferredRevenue
13859000 USD
CY2020Q2 cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
2300000 USD
cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
3500000 USD
CY2019Q2 cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
2200000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11394000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
588000 USD
cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
4200000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
15500000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
761705
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
295699
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
600000
cutr Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
707555
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
46128
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
44177
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
44177
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
39.07
cutr Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
364555
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1062882
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
205394
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.33
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4095000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2519000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6075000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3826000 USD
us-gaap Net Income Loss
NetIncomeLoss
-23808000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7632000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17055000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14086000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15744000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14051000
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.04
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14051000
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15744000
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
270000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17055000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14356000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.51
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1163000
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
370000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1192000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1182000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000 USD
CY2020Q2 cutr Lease Rightofuse Asset
LeaseRightofuseAsset
8284000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
7788000 USD
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
501000 USD
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
345000 USD
CY2020Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
846000 USD
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
277000 USD
CY2020Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
16000 USD
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
728000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
425000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
35000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1456000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
35000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
380000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1454000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2020Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.022 pure
CY2020Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.056 pure
CY2020Q2 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2020Q2 cutr Proceeds From Paycheck Protection Program Under Cares Act
ProceedsFromPaycheckProtectionProgramUnderCaresAct
7100000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
83800000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
26369000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
47774000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
58608000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
83800000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
26369000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
47774000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
58608000 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001162461
dei Entity Registrant Name
EntityRegistrantName
CUTERA INC
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17593798
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1796000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1355000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14315586
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17567688
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17567688
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14315586
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11681000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12685000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20423000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30307000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1339000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4733000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6411000 USD
CY2020Q2 us-gaap Assets
Assets
113417000 USD
CY2019Q4 us-gaap Assets
Assets
113738000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2303000 USD
CY2020Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2303000 USD
CY2019Q4 cutr Debt Securities Availableforsale Net Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableforsaleNetAccumulatedGrossUnrealizedGainLossBeforeTax
0 USD
CY2019Q4 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33659000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26316000 USD
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
12894000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7605000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13826000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21556000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
31240000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
33921000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5313000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5648000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
96932000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
95046000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2417000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2817000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
419000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
423000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7577000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7702000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
1339000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1526000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2800000 USD
CY2020Q2 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
1660000 USD
CY2019Q4 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
1999000 USD
CY2020Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9345000 USD
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10831000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
44635000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
58622000 USD
CY2020Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2434000 USD
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3391000 USD
CY2020Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
93000 USD
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
93000 USD
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
7149000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
0 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6262000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5112000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
345000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
578000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
60918000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
67796000 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
14000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
112644000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
82346000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60166000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36358000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-60000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
52499000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
45942000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113417000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113738000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
26369000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
47774000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
58608000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
83800000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14745000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21943000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32648000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
40660000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
299000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
11624000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
25831000 USD
us-gaap Gross Profit
GrossProfit
25960000 USD
us-gaap Gross Profit
GrossProfit
43140000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11035000 USD
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16992000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
25823000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
33096000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2991000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3273000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6862000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6979000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8529000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5267000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16336000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10792000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
22555000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
25532000 USD
us-gaap Operating Expenses
OperatingExpenses
49021000 USD
us-gaap Operating Expenses
OperatingExpenses
50867000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10931000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-23061000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7727000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
46000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-204000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-33000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10928000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
345000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-23265000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7760000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
466000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-243000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
543000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-128000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11394000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
588000 USD
us-gaap Net Income Loss
NetIncomeLoss
-23808000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7632000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17055000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14086000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15744000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14051000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17055000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14356000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15744000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14051000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11394000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
588000 USD
us-gaap Net Income Loss
NetIncomeLoss
-23808000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7632000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
0 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
3000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
0 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
9000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-2000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-63000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-0 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
2000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
3000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
63000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
9000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
63000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11392000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
591000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23745000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7623000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
45942000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
437000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
411000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26496000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3117000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6075000 USD
us-gaap Net Income Loss
NetIncomeLoss
-23808000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
63000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
52499000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
33536000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
437000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
210000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26496000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-883000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4095000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11394000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
52499000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
46386000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
832000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
331000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-570000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3826000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7632000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
43182000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
39120000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
832000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
200000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-80000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2519000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
588000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
43182000 USD
us-gaap Net Income Loss
NetIncomeLoss
-23808000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7632000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6075000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3826000 USD
us-gaap Depreciation
Depreciation
715000 USD
us-gaap Depreciation
Depreciation
815000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1392000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1412000 USD
us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
805000 USD
us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1696000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-19000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
198000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
151000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6034000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5263000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2681000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1125000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-316000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
614000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
519000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2303000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3117000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
570000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
380000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1752000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1004000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
162000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-9754000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3779000 USD
cutr Increase Decrease In Extended Product Warranty Accrual
IncreaseDecreaseInExtendedProductWarrantyAccrual
-339000 USD
cutr Increase Decrease In Extended Product Warranty Accrual
IncreaseDecreaseInExtendedProductWarrantyAccrual
-760000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-140000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2443000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1293000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-301000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17951000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3919000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
435000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
316000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
20000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
10900000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
9600000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
16167000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4020000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5702000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5284000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
848000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1163000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7149000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28799000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
342000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30996000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
251000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7343000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1616000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26316000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26052000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33659000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27668000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
27000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
903000 USD
CY2019Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2708000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1960000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
4152000 USD
CY2020Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1343000 USD
CY2019Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1940000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
3206000 USD
cutr Reduction In Board Of Directors Fees In Response To Covid19 Outbreak Percentage
ReductionInBoardOfDirectorsFeesInResponseToCOVID19OutbreakPercentage
0.25 pure
cutr Reduction In Salaries Of Chief Executive Officer President Chief Operating Officer And Some Managers In Response To Covid19 Outbreak Percentage
ReductionInSalariesOfChiefExecutiveOfficerPresidentChiefOperatingOfficerAndSomeManagersInResponseToCovid19OutbreakPercentage
0.25 pure
cutr Reduction In Salaries Of Employees And Furloughs In Response To Covid19 Outbreak Percentage Of Workforce
ReductionInSalariesOfEmployeesAndFurloughsInResponseToCovid19OutbreakPercentageOfWorkforce
0.42 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i><b>Use of Estimates</b></i></p> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </p> <p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates. </p> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </p> <p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commission, allowance for credit losses, and sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, incremental borrowing rates related to the Company’s leases, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, fair value of investments, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p>
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1800000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1400000 USD
CY2020Q2 cutr Accounts Receivable Provision For Loss Reversal
AccountsReceivableProvisionForLossReversal
1200000 USD
cutr Accounts Receivable Provision For Loss Reversal
AccountsReceivableProvisionForLossReversal
1800000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
200000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1300000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
-0 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
46553000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
33921000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
17935000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
-0 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
46550000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
33921000 USD
CY2020Q2 cutr Debt Securities Availableforsale Net Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableforsaleNetAccumulatedGrossUnrealizedGainLossBeforeTax
3000 USD
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
12894000 USD
CY2020Q2 cutr Available For Sale Securities Debt Maturities Year Two Through Three Fair Value
AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughThreeFairValue
0 USD
CY2020Q2 cutr Available For Sale Securities Including Restricted Investments
AvailableForSaleSecuritiesIncludingRestrictedInvestments
12894000 USD
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
17678000 USD
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2175000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2016000 USD
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11387000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13970000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
31240000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
33921000 USD
CY2020Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
7880000 USD
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
14341000 USD
CY2020Q2 cutr Accrued Sales And Marketing Costs Current
AccruedSalesAndMarketingCostsCurrent
1289000 USD
CY2019Q4 cutr Accrued Sales And Marketing Costs Current
AccruedSalesAndMarketingCostsCurrent
2527000 USD
CY2020Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3155000 USD
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
4401000 USD
CY2020Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2619000 USD
CY2019Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3922000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5480000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5116000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20423000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30307000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3398000 USD
CY2019Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4064000 USD
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4401000 USD
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4668000 USD
CY2020Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1100000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
3988000 USD
CY2020Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3155000 USD

Files In Submission

Name View Source Status
0001437749-20-017101-index-headers.html Edgar Link pending
0001437749-20-017101-index.html Edgar Link pending
0001437749-20-017101.txt Edgar Link pending
0001437749-20-017101-xbrl.zip Edgar Link pending
cutr-20200630.xsd Edgar Link pending
cutr-20200630_cal.xml Edgar Link unprocessable
cutr-20200630_def.xml Edgar Link unprocessable
cutr-20200630_lab.xml Edgar Link unprocessable
cutr-20200630_pre.xml Edgar Link unprocessable
cutr20200630_10q.htm Edgar Link pending
cutr20200630_10q_htm.xml Edgar Link completed
ex_195766.htm Edgar Link pending
ex_195767.htm Edgar Link pending
ex_195768.htm Edgar Link pending
ex_196723.htm Edgar Link pending
ex_196724.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
logo1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending